However, many individuals with weight loss resistance or obesity have genetically lower baseline GLP-1 production or poor receptor sensitivity, making dietary changes alone insufficient
3 Although several factors contributed to this rise in interest, two key developments have been particularly important: Celebrity endorsement: A number of high-profile celebrities, such as Elon Musk, have publicly credited GLP-1RA drugs with their transformative weight loss, leading to a spike in public interest in using the drugs for weight loss
[36], in a real-world cohort treated with GLP-1 RAs including exenatide, observed a mean BW loss of 2.5 kg and a BMI reduction of 0.9 kg/m without a significant change in intrahepatic lipid content, reflecting variability in hepatic responses across populations
T., Brody, M
These symptoms usually dissipate quickly
GLP1-RAs have been helpful to support better dietary habits which in turn is supportive of reducing inflammation and overall health